Delivery Order SPE2DB20D1109-SPE2DB25FP47R
Award Date 7/29/25
Potential Completion Date 8/19/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,374.96 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization protection against measles, mumps, rubella, and varicella, commonly used within military and federal...
- The Defense Logistics Agency awarded a delivery order for ProQuad vials valued at $3,374.96 to AmerisourceBergen Drug Corp on July 29, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded contract. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $8,354.50 under a firm fixed-price contract. The award was made on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside, competitively awarded delivery order, with performance to take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,308.68 to AmerisourceBergen Drug Corp for ProQuad vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance to be completed at the contractor's Conshohocken, Pennsylvania facility. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, indicating this delivery supports...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing the type of critical medical supply that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,740.40 with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $33,086.60 delivery order to AmerisourceBergen Drug Corp for ProQuad vials under a firm fixed price contract. This non-set-aside award was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. ProQuad is a combination vaccine that protects against measles, mumps, rubella, and varicella, making this a critical pharmaceutical supply for military medical readiness and vaccine administration programs across the Department of Defense. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,686.44 to AmerisourceBergen Drug Corp for ProQuad vials on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, will supply ProQuad, a combination vaccine used for...
- The Defense Logistics Agency awarded a $3,341.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitive award, issued without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. ProQuad is a combination vaccine protecting...